Why Augmedics isn't rushing to IPO after landing an $83 million Series D

CEO Kevin Hykes spoke with Chicago Inno about what stood out to him about fundraising in 2023 and what's next for the company amid stunted exit activity.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 3, 2023 Category: Pharmaceuticals Authors: Alex Zorn Source Type: news